The role of chronic hypertension and sex hormones in tauopathy induced cognitive decline
Description: Hypertension is the number one most modifiable risk factor for dementia. Though the distribution of hypertension among men and women aged 30-79 is nearly equal, middle-aged women disproportionally suffer from reduced cognitive function. To this point, nearly two-thirds of all Americans with Alzheimer's disease (AD), the most common form of dementia, are women. Interestingly, research in animal models of hypertension show an increase in brain tau hyperphosphorylation, a hallmark of AD. However, many of these studies used only male hypertensive animals and we still have yet to identify a link between hypertension and cognitive decline in women. Because estrogen can regulate tau hyperphosphorylation I propose that the loss of estrogen in mid-life caused by menopause could be behind the increased susceptibility of hypertensive women to cognitive impairment. In this proposal I will focus on two major questions 1) what role does estrogen play in hypertension induced cognitive decline and 2) by what mechanism specific to hypertension can cognitive decline occur? I will use hypertensive male and female animals prone to cognitive decline to answer these questions. Mice will undergo cognitive testing and tissue samples will be collected to identify changes in protein expression or histological structure. The data acquired from this research is translationally relevant as it could be used to support guidelines for healthy brain aging in people with hypertension
Funder: American Heart Association
Amount: $144,600
Funding type: training
Funder scheme: Diversity Supplement
Start date: 2024-09-01
End date: 2026-08-31
Investigator: Sara Zarate (lead)
Institutions: Vanderbilt University Medical Center, Vanderbilt University Medical Center (VUMC)
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 0
Funder award ID: 24DIVSUP1273494
OpenAlex ID: G4286642896
